Signet Therapeutics is developing new medicines to improve the lives of patients diagnosed with cancer, especially those cancers which are insensitive to chemotherapy and radiotherapy. 

By strategically collaborating with Xtalpi ,we bring together the expertise of AI-powered drug discovery platform to design and develop the compounds, and novel unique disease models to select and optimize the leads. By taking these advantages, we are revolutionizing the traditional drug discovery for small molecules.